Sven Dethlefs Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

Sven Dethlefs is EVP, North America Commercial of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 165,381 shares of TEVA, which is worth approximately $2.89 Million. The most recent transaction as insider was on Mar 07, 2023, when has been sold 58,066 shares (Ordinary Shares) at a price of $9.43 per share, resulting in proceeds of $547,562. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 165K

0% 3M change

0% 12M change

Total Value Held $2.89 Million

Sven Dethlefs Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2023	SELL Open market or private sale	$547,562 $9.43 p/Share	58,066 Reduced 25.99%	165,381 Ordinary Shares
Mar 06 2023	SELL Open market or private sale	$192,195 $9.93 p/Share	19,355 Reduced 7.97%	223,447 Ordinary Shares
Mar 05 2023	BUY Exercise of conversion of derivative security	-	24,952 Added 9.32%	242,802 Ordinary Shares
Mar 04 2023	BUY Exercise of conversion of derivative security	-	52,469 Added 19.41%	217,850 Ordinary Shares
Feb 28 2023	SELL Open market or private sale	$589,987 $9.89 p/Share	59,655 Reduced 26.51%	165,381 Ordinary Shares
Feb 28 2023	BUY Exercise of conversion of derivative security	-	59,655 Added 22.31%	207,690 Ordinary Shares
Mar 07 2022	SELL Open market or private sale	$51,538 $7.37 p/Share	6,993 Reduced 4.06%	165,381 Ordinary Shares
Mar 05 2022	BUY Exercise of conversion of derivative security	-	24,952 Added 12.65%	172,374 Ordinary Shares
Mar 04 2022	SELL Open market or private sale	$29,202 $7.48 p/Share	3,904 Reduced 2.58%	147,422 Ordinary Shares
Mar 04 2022	BUY Exercise of conversion of derivative security	-	51,869 Added 25.53%	151,326 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$39,577 $8.14 p/Share	4,862 Reduced 4.66%	99,457 Ordinary Shares
Feb 28 2022	BUY Exercise of conversion of derivative security	-	17,346 Added 14.26%	104,319 Ordinary Shares
Feb 09 2022	SELL Open market or private sale	$37,490 $9.06 p/Share	4,138 Reduced 4.54%	86,973 Ordinary Shares
Feb 09 2022	BUY Exercise of conversion of derivative security	-	13,135 Added 12.6%	91,111 Ordinary Shares
Mar 04 2021	SELL Open market or private sale	$63,547 $10.57 p/Share	6,012 Reduced 7.16%	77,975 Ordinary Shares
Mar 04 2021	BUY Exercise of conversion of derivative security	-	13,930 Added 14.23%	83,987 Ordinary Shares
Mar 03 2021	SELL Open market or private sale	$6,581 $10.86 p/Share	606 Reduced 0.86%	70,057 Ordinary Shares
Mar 03 2021	BUY Exercise of conversion of derivative security	-	1,400 Added 1.94%	70,663 Ordinary Shares
Mar 01 2021	SELL Open market or private sale	$81,073 $10.83 p/Share	7,486 Reduced 9.75%	69,263 Ordinary Shares
Feb 28 2021	BUY Exercise of conversion of derivative security	-	17,346 Added 18.43%	76,749 Ordinary Shares
Feb 09 2021	SELL Open market or private sale	$376,347 $12.69 p/Share	29,657 Reduced 33.3%	59,403 Ordinary Shares
Feb 09 2021	BUY Grant, award, or other acquisition	-	55,287 Added 38.3%	89,060 Ordinary Shares
Feb 09 2021	BUY Exercise of conversion of derivative security	-	13,135 Added 28.0%	33,773 Ordinary Shares

Sven Dethlefs

EVP, North America Commercial

Tel Aviv, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Value

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA

Account